corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13199

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Watson R.
European Commission looks into possible restrictive practices by drug companies
BMJ 2008 Mar 8; 336:(7643):524
http://www.bmj.com/cgi/content/extract/336/7643/524-a


Abstract:

The falling number of new drugs coming onto the market has prompted the European Commission to launch its first major investigation into the pharmaceutical sector to determine whether manufacturers are engaging in illegal restrictive practices.

The commission points to the downward trend in the development of new drugs to explain its suspicion that market forces are not operating satisfactorily. Between 1995 and 1999 an average of 40 novel molecular entities were launched each year in the European Union. Over the next five years the number fell to 28.

Announcing the investigation, Neelie Kroes, the EU’s competition commissioner, said, “If innovative products are not being produced, and cheaper generic alternatives to existing products are in some cases being delayed, then we need to find out why and, if necessary, take action.”

The inquiry is now in its seventh week. It is not expected to deliver its preliminary findings before the autumn, . . .

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909